Products

Qritive Pantheon
Qritive
Oncology AI
Qritive's Pantheon is an AI-powered digital pathology platform that assists pathologists in identifying, grading, and classifying cancer with precision, integrating into digital pathology workflows. The platform is vendor-agnostic and cloud-ready, supporting remote access and telepathology.

See all 1 product →

About Qritive

Qritive is a healthcare AI company that develops advanced digital pathology solutions to enhance cancer diagnosis and improve patient outcomes. Their core offering includes AI-powered modules that assist pathologists in the identification, grading, and classification of various cancers, such as colon, prostate, lymph node, and breast, along with biomarker analysis. [19] These modules are designed to be hardware-agnostic, allowing for seamless integration into existing digital pathology workflows and platforms, including Qritive’s own Pantheon™ system. [19]

The Pantheon™ platform serves as an AI-powered pathology workbench, providing a single-window operation that integrates with a remote-accessible patient management system. [19] This platform streamlines the pathology workflow from end-to-end, offering tools for case management, reporting, slide viewing and analysis, telepathology, synoptic reporting, and LIS integration. [2, 3] Qritive’s solutions are CE certified and approved by the Singapore Health Sciences Authority (HSA) for clinical use, demonstrating their commitment to clinical-grade AI. [2, 3] By leveraging deep learning technology, Qritive aims to address challenges in pathology such as slow turnaround times, inconsistent diagnoses, and workflow inefficiencies, ultimately enabling faster, more accurate diagnoses and reducing the time to treatment for patients. [7, 15]

Focus Areas

digital pathology AI in healthcare cancer diagnosis oncology image analysis computational pathology

Business Intelligence

Key InvestorsMassMutual Ventures, SEEDS Capital, Exfinity Venture Partners, GE Healthcare, Pix Vine Capital, Entrepreneurs First, Acequia Capital (AceCap), MMV Europe & Asia-Pacific
PartnershipsRoche, Metropolis Healthcare, CŌRE Diagnostics, Rajiv Gandhi Cancer Institute, Corista, Singapore General Hospital, National University Hospital (NUH), Philips, Hewlett Packard Enterprise (HP)
Technologycloud-native, deep learning technology, AI operating system (Pantheon digital pathology platform)

What Physicians Need to Know

Digital Pathology & AI in Healthcare
Qritive specializes in AI-powered digital pathology solutions that assist pathologists in identifying, grading, and classifying cancer with precision. Their offerings include AI modules for prostate, colon, breast, and gastric cancers, lymph node metastasis, and biomarker analysis.
Cancer Diagnosis & Oncology
The company's core mission is to make cancer diagnosis faster, more accurate, and more affordable by leveraging AI and image analytics. Their solutions aim to reduce interpretation variability, improve consistency, and accelerate turnaround times in pathology.
Image Analysis & Computational Pathology
Qritive utilizes cutting-edge deep learning technology to provide automated interpretation of pathology assessments from whole-slide images (WSIs). Their platform, Pantheonu2122, is an AI-powered pathology workbench for advanced slide viewing, reading, and analysis.
Key Differentiators
Qritive's solutions are hardware-agnostic and designed for seamless integration into any digital pathology workflow or platform. They offer a comprehensive platform with powerful diagnostic modules, an advanced image management system, and seamless workflow integration. Their AI modules are clinically validated and scientifically recognized.
Technology Stack
The company leverages deep learning technology for its AI modules. Their Pantheonu2122 platform is a vendor-agnostic, cloud-ready image management system that supports remote access and telepathology. They also focus on building customized applications for cloud-based data sharing.
Physician Tip

For physicians, Qritive's solutions offer the potential for faster, more accurate, and consistent cancer diagnoses, reducing the risk of misdiagnosis and accelerating time to treatment. The AI modules can assist in identifying, grading, and classifying various cancers, including prostate, colon, breast, and gastric, as well as lymph node metastasis and biomarker quantification. The Pantheonu2122 platform provides a seamless single-window operation for slide viewing, case management, and AI-supported diagnosis, enhancing workflow efficiency and enabling remote collaboration. The hardware-agnostic nature of their solutions ensures compatibility with existing digital pathology infrastructure.

Qritive's AI modules are designed to integrate seamlessly with various digital pathology workflows and platforms, including their own Pantheonu2122 system and other image management systems. They have a significant collaboration with Roche, integrating their AI-powered solutions with the Roche navifyu00ae Digital Pathology platform to streamline cancer diagnostics. Additionally, they partner with companies like Corista to integrate their AI modules with image management platforms like DP3. Pantheonu2122 also supports integration with major LIS, EMR, PACS, and other hospital information systems.

Products by Qritive

1 product in the directory

Qritive Pantheon
Qritive
Oncology AI
Qritive's Pantheon is an AI-powered digital pathology platform that assists pathologists in identifying, grading, and classifying cancer with precision, integrating into digital pathology workflows. The platform is vendor-agnostic and cloud-ready, supporting remote access and telepathology.

Reviews & Opinions

No web reviews on file yet for Qritive. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Qritive.

Loading videos...

Videos load interactively. If none appear, search YouTube for Qritive →

View all on YouTube

Press & Coverage

National Reference Laboratory
National Reference Laboratory Introduce UAE Breakthrough in AI- M42's Powered Prostate Cancer Diagnostics with Qritive
M42's National Reference Laboratory (NRL) in the UAE has partnered with Qritive to implement advanced AI-powered prostate cancer diagnostics, aiming for faster, more accurate, and consistent patient care. This collaboration addresses rising diagnostic demand and pathology workforce pressures by integrating Qritive's AI Prostate module into NRL's workflow.
2026-06
Qritive
Qritive receives Class C IVD certification from the Health Sciences Authority (HSA) Singapore for its QAi Prostate Dx module.
Qritive announced that its QAi Prostate Dx module has received Class C IVD certification from the Health Sciences Authority (HSA) Singapore, a significant step in expanding AI's clinical use in prostate cancer diagnostics.
2025-06
Qritive
Launching Qritive Academy: Expanding Access to Pathology Education
Qritive launched Qritive Academy, an online platform for continuous learning and professional development in pathology, offering foundational and advanced content to make high-quality education more accessible globally.
2025-09
Qritive
Dr Lal PathLabs Selects Qritive's AI-Powered Solution to Strengthen Cancer Diagnostics
Dr Lal PathLabs, a leading diagnostic provider in India, has chosen Qritive's AI-powered solution to enhance its cancer diagnostics capabilities.
2025-08
PR Newswire
Qritive Joins Forces with Roche to Redefine Global Cancer Diagnostics with AI
Qritive announced a collaboration with Roche to integrate its AI-powered solutions with the Roche navify Digital Pathology platform, aiming to improve cancer diagnosis accuracy and efficiency, and reduce time to treatment.
2024-09
Business Standard
Metropolis Healthcare partners with Singapore-based Qritive for advanced Cancer Diagnosis through AI
Metropolis Healthcare Limited in India has partnered with Qritive to enhance its cancer diagnosis capabilities through the integration of AI technology, including Qritive's Pantheonu2122 image management system and AI products.
2024-02
BioPharma APAC
Healthcare AI Firm Qritive Raises $7.5M to Expand into New Markets
Qritive, a healthcare AI startup, raised $7.5 million in a funding round led by MassMutual Ventures, with participation from SEEDS Capital and Exfinity Venture Partners, to drive geographical expansion, expand its product portfolio, and support regulatory clearances.
2023-01
PR Newswire
Qritive Launches QAi Prostate: Advanced AI-Powered Prostate Cancer Diagnosis Tool for Pathologists
Qritive launched QAi Prostate, an advanced AI-powered tool designed to assist pathologists in diagnosing prostate cancer more efficiently and accurately.
2023-03

Frequently Asked Questions

Qritive's AI aims to enhance the accuracy and efficiency of cancer diagnosis by providing tools for automated image analysis of pathology slides. This can help pathologists identify subtle features, quantify biomarkers, and reduce inter-observer variability, ultimately leading to more consistent and potentially faster diagnoses.
Qritive's solutions are designed for seamless integration with various digital pathology scanners and LIS platforms. They often utilize open standards and APIs to ensure compatibility, minimizing disruption to current laboratory workflows and enabling a smooth transition to AI-assisted diagnostics.
Qritive prioritizes regulatory compliance, holding key clearances such as CE-IVD for in-vitro diagnostic use in Europe and striving for FDA clearance in the United States. They also adhere to data privacy and security regulations like HIPAA to ensure patient data protection.
Qritive typically offers flexible pricing models that may include per-slide fees, subscription-based access, or enterprise licenses. Factors influencing the cost often include the volume of cases, the specific AI modules utilized, and the level of integration and support required.
Qritive provides comprehensive training programs for pathologists and laboratory staff to ensure effective utilization of their AI solutions. This includes initial onboarding, ongoing technical support, and regular updates to help users maximize the benefits of the technology.
Qritive actively collaborates with leading healthcare technology companies and research institutions to advance digital pathology and AI in oncology. These partnerships often focus on co-development of new AI algorithms, validation studies, and expanding market reach.
Qritive's long-term vision is to become a leader in AI-powered precision diagnostics, continuously expanding its portfolio of AI algorithms and global presence. The company demonstrates stability through successful funding rounds, strategic partnerships, and a growing customer base, indicating a strong growth trajectory.

Related Companies

QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]

Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.